Sign in
4

Changes in Ownership

UroGen Pharma Ltd. Filed Acc 0001209191-20-034672

Chief Medical Officer sold 349 shares at $27.51 ($9,602)

  • Chief Medical Officer acquired 1,042 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schoenberg Mark Chief Medical Officer 2020-06-04 Option exercise +1,042 18,753 D: show line 1 in the form
Schoenberg Mark Chief Medical Officer 2020-06-04 Sale −349 $27.51 $9,602 18,404 D: show line 2 in the form
Open-market sales · 349 sh · avg $27.51 · $9,602

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Schoenberg Mark Chief Medical Officer 2020-06-04 Option exercise · Restricted Stock Units −1,042 1,042 2,083 D: show line 3 in the form
Loading xslF345X03/doc4.xml…